ERBB2 and breast carcinoma: Therefore, the aims of this work were: (i) to develop a PBPK model of MBQ-167 after intraperitoneal (IP) administration in mice, and (ii) to characterize tumor growth dynamics in two human breast cancer cell lines (HER2+ and Triple Negative).